Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Polar Capital Healthcare Opportunities USD

Managed by

Daniel Mahony

Daniel Mahony joined Polar Capital in 2007, and manages the Polar Capital Healthcare Opportunities Fund using a growth investment style. Prior to this he was a senior analyst at Morgan Stanley, having also been an associate at ING Barings Furman Selz. Daniel studied at Christ Church College, Oxford and St John's College, Cambridge where he earned a PhD in biochemistry. He is currently based in London and his interests outside of work include rugby, soccer, the cinema and cheese making.

Gareth Powell

Gareth Powell is a fund manager for Polar Capital where he has worked since 2007. Powell invests in global healthcare equities, favouring a growth investment strategy. Powell uses active fund management style, and is willing to change his portfolio and investment style as he identifies changes in the market. He believes changes in his investment style have been largely driven by macro-economics, resulting in an increased tactical focus. Powell began his career as an analyst and later became a fund manager for Framlington after graduating from Oxford University with a degree in Biochemistry. Powell enjoys a number of sports outside of work, including golf and rugby, as well as music and the theatre.


The investment objective of the Fund is to preserve capital and achieve long-term capital appreciation, by investing in a globally diversified portfolio of healthcare companies. The Fund seeks to outperform a benchmark index - the MSCI Global Health Care Index.

This fund is not currently tracked by Citywire in Lithuania View performance globally

Registered For Sale In

  1. Austria
  2. Belgium
  3. Denmark
  4. Finland
  5. France
  6. Germany
  7. Guernsey
  8. Ireland
  9. Italy
  10. Jersey
  11. Luxembourg
  12. Netherlands
  13. Norway
  14. Singapore
  15. Spain
  16. Sweden
  17. Switzerland
  18. United Kingdom

Related News

Pfizer power play: healthcare stars react to $14bn deal

Citywire Selector canvassed sector specialists on what the pharma giant’s latest purchase means for M&A and long-term investments.